Journal Article DKFZ-2022-01785

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2017
Impact Journals LLC [S.l.]

OncoTarget 8(57), 97290 - 97303 () [10.18632/oncotarget.21932]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: Atypical teratoid rhabdoid tumor (ATRT) is an aggressive and malignant pediatric brain tumor. Polo-like kinase 1 (PLK1) is highly expressed in many cancers and essential for mitosis. Overexpression of PLK1 promotes chromosome instability and aneuploidy by overriding the G2-M DNA damage and spindle checkpoints. Recent studies suggest that targeting PLK1 by small molecule inhibitors is a promising approach to tumor therapy. We investigated the effect of PLK1 inhibition in ATRT. Gene expression analysis showed that PLK1 was overexpressed in ATRT patient samples and tumor cell lines. Genetic inhibition of PLK1 with shRNA potently suppressed ATRT cell growth in vitro. Treatment with the PLK1 inhibitor BI 6727 (Volasertib) significantly decreased cell growth, inhibited clonogenic potential, and induced apoptosis. BI6727 treatment led to G2-M phase arrest, consistent with PLK1's role as a critical regulator of mitosis. Moreover, inhibition of PLK1 by BI6727 suppressed the tumor-sphere formation of ATRT cells. Treatment also significantly decreased levels of the DNA damage proteins Ku80 and RAD51 and increased γ-H2AX expression, indicating that BI 6727 can induce DNA damage. Importantly, BI6727 significantly enhanced radiation sensitivity of ATRT cells. In vivo, BI6727 slowed growth of ATRT tumors and prolonged survival in a xenograft model. PLK1 inhibition is a compelling new therapeutic approach for treating ATRT, and the use of BI6727 should be evaluated in clinical studies.

Keyword(s): ATRT ; Polo-like kinase 1 ; SMARCB1 ; volasertib

Classification:

Contributing Institute(s):
  1. B062 Pädiatrische Neuroonkologie (B062)
Research Program(s):
  1. 312 - Functional and structural genomics (POF3-312) (POF3-312)

Appears in the scientific report 2017
Database coverage:
Medline ; PubMed Central ; SCOPUS
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2022-08-12, last modified 2024-03-01


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)